Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2011

Jan 5, 2011

30681_dirs_2011-01-05_1354250e-d8d9-4ad5-a98a-870ddf8bc6a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-01-03

Reporting Person: WILSON JAMES N (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-01-03 Common Stock S 10000 $3.8185 Disposed 2064511 Indirect
2011-01-03 Common Stock S 5000 $3.8185 Disposed 946774 Indirect

Footnotes

F1: Price shown is the average price. Price of the individual blocks sold ranged from $3.76 to $3.90 per share.